Corrective Assignment to Correct the the Execution Date and Add Application Number 62835825 and Pct Number US2028767 Previously Recorded at Reel: 59549 Frame: 310. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2025-03-07 Pages: 8

Assignors

FAN, JIE

Executed: 2020-04-15

HE, WEI

Executed: 2020-04-17

LIU, KE

Executed: 2020-04-15

Assignee

ACCUTAR BIOTECHNOLOGY INC.

ROOM 213, 760 PARKSIDE AVENUE, BROOKLYN, NEW YORK, 11226

Covered Properties (2)

Novel Compounds Having Bet, Estrogen Receptor, and Androgen Receptor Degradation Activity and Uses Thereof

Patent: 12,331,061 →

Application: 17/604,014 →

Publication: US 2022/0220124

PCT: PCT/US2020/028767 ↗

Novel Compounds Having Bet, Estrogen Receptor, and Androgen Receptor Degradation Activity and Uses Thereof

Application: 62/835,825 →

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.